Ziyuglycoside II (10-60 μM; 24 h and 48 h) inhibits MDA-MB-435 cells growth in a dose-dependent manner. The IC
50
of Ziyuglycoside II at 24 h and 48 h is 5.92 μM and 4.74 μM, respectively.
Ziyuglycoside II (5-25 μM) induces G0/G1 and S phase arrest in MDA-MB-435 cells at 24 h.
Ziyuglycoside II (5-25 μM; 24 hours) significantly increases apoptotic rate of MDA-MB-435 cells.
Ziyuglycoside II (5-25 μM; 24 hours) increases expressions of both p53 and p21 in MDA-MB-435 cells, which effect is dose-dependent.
Cell Viability Assay
Cell Line: | MDA-MB-435 cells |
Concentration: | 10, 20, 30, 40, 50, 60 μM |
Incubation Time: | 24 hours and 48 hours |
Result: | The IC 50 at 24 h and 48 h was 5.92 μM and 4.74 μM, respectively. |
Cell Cycle Analysis
Cell Line: | MDA-MB-435 cells |
Concentration: | 5, 10, 25 μM |
Incubation Time: | 24 hours |
Result: | Induced G0/G1 and S phase arrest. |
Apoptosis Analysis
Cell Line: | MDA-MB-435 cells |
Concentration: | 5, 10, 25 μM |
Incubation Time: | 24 hours |
Result: | The apoptotic rate was significantly increased in comparison to that of the control. |
Western Blot Analysis
Cell Line: | MDA-MB-435 cells |
Concentration: | 5, 10, 25 μM |
Incubation Time: | 24 hours |
Result: | Treatment resulted in increased expressions of both p53 and p21. |